Dyshidrotic Eczema is NOT Simply Atopic Dermatitis on the Feet
Dyshidrotic eczema (also called pompholyx or acute vesicular dermatitis) is a distinct clinical entity that can occur as part of the atopic dermatitis spectrum, but it is not merely "atopic dermatitis on the feet." While these conditions may overlap or coexist, they represent different clinical presentations with distinct characteristics.
Key Distinguishing Features
Clinical Presentation
Dyshidrotic eczema presents with characteristic deep-seated vesicles on the palms, soles, and sides of fingers and toes 1, 2. This vesicular pattern is its defining feature, whereas classic atopic dermatitis typically shows:
- Symmetrical distribution with age-specific patterns 3
- Flexural involvement (elbows, knees, neck) 4
- Erythema, xerosis, and lichenification rather than vesicles 5
Relationship to Atopic Dermatitis
The evidence shows dyshidrotic eczema exists on a spectrum:
- It is "often considered on the spectrum of atopic dermatitis" but remains a distinct entity 1
- Recent data suggests it follows "a clinical course less dependent on external or occupational triggers" compared to other hand eczema subtypes, pointing toward greater endogenous factors 6
- Only 16% of dyshidrotic eczema cases show palmoplantar involvement versus 7% in non-dyshidrotic hand eczema 6
Clinical Implications for Diagnosis
When to Suspect Dyshidrotic Eczema Rather Than Atopic Dermatitis:
- Vesicular eruptions on palms/soles (not typical for AD)
- Longer disease duration (median 24 months vs 14 months for other hand eczema) 6
- Lower rates of contact allergen sensitization (43% vs 52% in other hand eczema) 6
- Less frequent occupational triggers (9% vs 29%) 6
Important Diagnostic Pitfall
One guideline notes that unusual distribution patterns on the sides of the feet may suggest allergic contact dermatitis rather than typical atopic dermatitis 7. This highlights that foot involvement with atypical patterns warrants patch testing to rule out contact allergy.
Treatment Considerations
The distinction matters therapeutically because:
- Dyshidrotic eczema responds to atopic dermatitis-targeted biologics (dupilumab, tralokinumab) 1, 2
- This suggests shared immunologic pathways (Th2/IL-13 mediated)
- However, the vesicular nature may require specific management approaches beyond standard AD treatment
Treatment Algorithm:
- First-line: Topical corticosteroids (medium-to-high potency for palms/soles given thicker skin)
- Refractory cases: Consider biologics targeting IL-4/IL-13 pathways (dupilumab, tralokinumab) 1, 2
- Evaluate for triggers: Patch testing if contact dermatitis suspected, especially with atypical patterns 7, 6
Bottom Line
Dyshidrotic eczema is a specific vesicular dermatitis pattern that may share immunologic features with atopic dermatitis but is not simply AD occurring on the feet. The vesicular morphology, palmoplantar distribution, and relatively greater role of endogenous factors distinguish it from classic atopic dermatitis, though both may coexist in the same patient and respond to similar immunomodulatory treatments.